BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10923696)

  • 1. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction.
    Campbell KM; Veldman MB; McGrath MJ; Burton FH
    Neuroreport; 2000 Jul; 11(10):2335-8. PubMed ID: 10923696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.
    McGrath MJ; Campbell KM; Parks CR; Burton FH
    Brain Res; 2000 Sep; 877(1):23-30. PubMed ID: 10980239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of striatal desensitization in cortical-limbic hyperglutamatergic TS- & OCD-like transgenic mice.
    O'Brien KB; Sharrief AZ; Nordstrom EJ; Travanty AJ; Huynh M; Romero MP; Bittner KC; Bowser MT; Burton FH
    J Chem Neuroanat; 2018 Apr; 89():11-20. PubMed ID: 29481900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion.
    Campbell KM; McGrath MJ; Burton FH
    Brain Res; 1999 Jul; 833(2):216-24. PubMed ID: 10375697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior.
    McGrath MJ; Campbell KM; Burton FH
    Behav Neurosci; 1999 Dec; 113(6):1249-56. PubMed ID: 10636303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome.
    Nordstrom EJ; Bittner KC; McGrath MJ; Parks CR; Burton FH
    Brain Res; 2015 Dec; 1629():38-53. PubMed ID: 26453289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons.
    Campbell KM; de Lecea L; Severynse DM; Caron MG; McGrath MJ; Sparber SB; Sun LY; Burton FH
    J Neurosci; 1999 Jun; 19(12):5044-53. PubMed ID: 10366637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.
    Campbell KM; McGrath MJ; Burton FH
    Eur J Pharmacol; 1999 Apr; 371(2-3):103-11. PubMed ID: 10357247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior.
    McGrath MJ; Campbell KM; Veldman MB; Burton FH
    Behav Pharmacol; 1999 Sep; 10(5):435-43. PubMed ID: 10780249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Back to the Future: Circuit-testing TS & OCD.
    Burton FH
    J Neurosci Methods; 2017 Dec; 292():2-11. PubMed ID: 28756273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrality of prefrontal and motor preparation cortices to Tourette Syndrome revealed by meta-analysis of task-based neuroimaging studies.
    Polyanska L; Critchley HD; Rae CL
    Neuroimage Clin; 2017; 16():257-267. PubMed ID: 28831377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.
    Godar SC; Mosher LJ; Strathman HJ; Gochi AM; Jones CM; Fowler SC; Bortolato M
    Br J Pharmacol; 2016 Jul; 173(13):2111-21. PubMed ID: 26171666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
    Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
    Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome.
    Fowler SC; Mosher LJ; Godar SC; Bortolato M
    J Neurosci Methods; 2017 Dec; 292():37-44. PubMed ID: 28099872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal analysis of Fos expression associated with cocaine- and PTZ-induced seizures in prenatally cocaine-treated rats.
    Snyder-Keller A; Keller RW
    Exp Neurol; 2001 Jul; 170(1):109-20. PubMed ID: 11421588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.
    Watanabe M; Miyai A; Danjo S; Nakamura Y; Itoh K
    Exp Neurol; 2013 Sep; 247():645-52. PubMed ID: 23499834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
    Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
    J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The α6 GABA
    Cadeddu R; Knutson DE; Mosher LJ; Loizou S; Odeh K; Fisher JL; Cook JM; Bortolato M
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33525455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.
    Groth C; Mol Debes N; Rask CU; Lange T; Skov L
    J Am Acad Child Adolesc Psychiatry; 2017 Apr; 56(4):304-312. PubMed ID: 28335874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.